Symptom-focussed pharmacotherapy in borderline personality disorder;Symptomorientierte pharmakotherapie bei borderline-persönlichkeitsstörung

Fortschritte der Neurologie Psychiatrie

Volumn 69, Issue 7, 2001, Pages 310-321

  Schmahl, C ^a   Bohus, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; ANXIETY NEUROSIS; ARTICLE; AUTOMUTILATION; BORDERLINE STATE; COMPULSION; DEPRESSION; HUMAN; HYSTERIA; IMPULSIVENESS; MENTAL DISEASE; OBSESSION; PSYCHOSIS; SLEEP DISORDER; SUICIDAL BEHAVIOR; SYMPTOM; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW;

BORDERLINE PERSONALITY DISORDER; HUMANS; PSYCHOTHERAPY;

EID: 0034742661     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15305     Document Type: Article

References (72)

1. The epidemiology of personality disorders: A 1990 update
2. Epidemiology, diagnosis and comorbidity of borderline personality disorder
3. Further data on dialectical behavior therapy
4. Die dialektisch-behaviorale psychotherapie nach M. Linehan
5. Comparative chemotherapeutic trial in treatment of chronic borderline patients
6. Psychiatric diagnosis and a typology of clinical drug effects
7. Pharmacotherapy for patients with borderline personality disorder
8. Is there any drug treatment of choice for the borderline personality disorder?
9. The Revised Diagnostic Interview for Borderlines: Discriminating borderline personality disorder from other Axis II disorders
10. Axis I diagnostic comorbidity and borderline personality disorder
11. Axis I comorbidity of borderline personality disorder
12. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders
13. Quality of depressive experience in borderline personality disorder and major depression: When depression is not just depression
14. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: A comparative study
15. Pharmacotherapy of impulsivity, aggression and related disorders
16. Lithium therapy for borderline patients: Preliminary findings
17. Fluoxetine in the treatment of borderline and schizotypal personality disorder
18. Fluoxetine trial in borderline personality disorder
19. Fluoxetina en el tratamiento de los tratornos limite de personalidad
20. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder
21. A trial of carbamazepine in borderline personality disorder
22. An open trial of valproate in borderline personality disorder
23. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo
24. Amitriptyline versus haloperidol in borderlines: Final outcomes and predictors of response
25. Paradoxical effects of amitriptyline in borderline patients
26. Efficacy of phenelzine and haloperidol in borderline personality disorder
27. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder
28. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects
29. Affective responsiveness in borderline personality disorder: A psychophysiological approach
30. Lithium carbonate in emotionally unstable character disorders
31. Genetics in borderline conditions
32. Affective and impulsive personality disorder traits in the relatives of borderline personality disorder patients
33. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder
34. An open trial of sertraline in personality disordered patients with impulsive aggression
35. Divalproex sodium as a treatment for borderline personality disorder
36. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia
37. Characteristics of borderline personality disorder associated with suicidal behavior
38. Lamotrigene as a promising approach to borderline personality: An open case series without concurrent DSM-IV major mood disorder
39. The dissociative experiences of borderline patients
40. Development, reliability and validity of a dissociation scale
41. Risk factors associated with the dissociative experience of borderline patients
42. Twin study of dissociative experience
43. Behandlung von dissoziativen symptomen bei borderline - Persönlichkeitsstörungen mit naltrexon
44. Naltrexone in the treatment of dissociative symptoms in patients with Borderline Personality Disorder: An open-label trial
45. Suicide gestures and self-mutilation
46. Self-injurious behavior and mood regulation
47. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior
48. Borderlinepersönlichkeitsstörungen
49. Remission of self-mutilation in a patient with borderline personality during risperidone therapy
50. Venlafaxine in the treatment of borderline personality disorder
51. Naltrexone as a treatment for repetitive self-injurious behavior: An open-label trial
52. Personality and suicide
53. The PI 500: Long-term follow-up of borderline inpatients meeting DSM-III criteria. I. Global outcome
54. Predictors of suicide in borderline personality disorder
55. Risk factors for suicidal behavior in borderline personality disorder
56. Borderline personality disorder symptoms and severity of sexual abuse
57. Symptoms and EEG findings in the borderline syndrome
58. Intent and lethality of suicide attempts among female borderline patients
59. Pharmacotherapy of borderline personality disorder: Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine
60. Alprazolam-induced dyscontrol in borderline personality disorder
61. Cognitive features of borderline personality disorder
62. Cyproheptadine for post-traumatic nightmares
63. Risperidone in comorbid borderline personality disorder and dysthymia
64. Fluoxetine in borderline personality disorder
65. Clozapine treatment of borderline patients: A preliminary study
66. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression
67. New biological research strategies for personality disorders
68. Cognitive-behavioral treatment of chronically suicidal borderline patients
69. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients
70. Der verlauf von borderline-störungen. Eine literatürubersicht